LRMR - Larimar Therapeutics, Inc.
IEX Last Trade
4
0 0%
Share volume: 11,911
Last Updated: Fri 27 Dec 2024 02:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$4.00
0.00
0.00%
Summary score
26%
Profitability
25%
Dept financing
6%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.73%
Return on assets
-11.93%
Return on sales
0%
Return on invested capital
517.92%
Total debt ratio
25.73%
Debt ratio change over timeo
-0.85%
Current Ratio
9.98%
Quick Ratio
0%
Cash Position Ratio
4.82%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.06%
Return on assets
-7.55%
Return on sales
0%
Return on invested capital
1161.86%
Total debt ratio
27.64%
Debt ratio change over timeo
-0.89%
Current Ratio
8.86%
Quick Ratio
0%
Cash Position Ratio
6.45%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-10.07%
Return on assets
-9.09%
Return on sales
0%
Return on invested capital
3789.3%
Total debt ratio
10.29%
Debt ratio change over time
-0.98%
Current Ratio
17.92%
Quick Ratio
0%
Cash Position Ratio
16.96%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-108.91%
Return on assets
-106.32%
Return on sales
0%
Return on invested capital
90.88%
Total debt ratio
-85.42%
Debt ratio change over time
-0.85%
Current Ratio
3.85%
Quick Ratio
0%
Cash Position Ratio
1.23%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LRMR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.73% | -3.05% | 11.55% | 6.27% |
| Return on assets | -11.93% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 517.92% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 36% | 67% | 59% |
| Total debt ratio | 25.73% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.85% | 6.09% | 6.03% | 1.53% |
| Dept financing | 6% | 50% | 43% | 14% |
| Current Ratio | 8.86% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 6.45% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 18% | 37% | 39% |
| Short-term ratios | LRMR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.06% | -25.62% | 17.94% | 7.14% |
| Return on assets | -7.55% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 1161.86% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 38% | 70% | 58% |
| Total debt ratio | 27.64% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.89% | -23.44% | 9.66% | 0.6% |
| Dept financing | 7% | 25% | 45% | 8% |
| Current Ratio | 8.86% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 6.45% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 29% | 24% | 41% |